Zusammenfassung
Größe und Gewicht der annähernd kastanienförmigen Prostata hängen von Alter und Hormonsituation ab (Literaturübersicht bei Aumüller 1979). Das Gewicht hegt bei 21–25 Jahre alten Männern zwischen 17 und 28 g. Die Maße an der Vorderfläche werden mit 3,1–4,2 cm für die Länge und 3,5–5 cm für die Breite angegeben. Der Sagittaldurchmesser der Prostata beträgt 1,7–2,3 cm. Das Drüsenparenchym umfaßt 30–50 Läppchen, zu denen 15–30 exkretorische Gänge gehören, die überwiegend in die Furchen lateral des Colliculus seminalis münden. Auf einem Querschnitt (Stieve 1930, Abb. 1) erkennt man die spalt—förmige Lichtung der Harnröhre, die symphysenwärts konvex gebuchtet ist. Der CoUiculus seminahs wölbt sich von dorsal herein. Eine Untergliederung in „Lappen”, wie sie LOWSLEY (1912) ursprünghch am Embryo beschrieben hat, ist nicht zu sehen, vielmehr lassen sich 3 konzentrisch angeordnete Regionen von zunehmender Größe erkennen (FRANKS 1954a): Im Zentrum liegt die Urethra. Die hufeisenförmig ausgebildete sog. Außendrüse bildet die Hauptmasse des Organs. Ventralwärts zur Blase hin ist das Hufeisen offen, hier sieht man Muskulatur, Bindegewebe und reichliche Gefäße, auch quergestreifte Muskelfasern strahlen hier ein. Die Außendrüse umschheßt eine kleine Gruppe von unterschiedlich langen Drüsen, die die sog. Innendrüse bilden. Außen—und Innendrüse sind durch eine oft wenig markante fibromuskuläre „Kapsel” voneinander getrennt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Abeshouse BS, Abeshouse GA (1961) Metastatic tumors of the penis: A review of the literature and a report of two cases. J Urol 86:99
Abrahamsson PA (1988) Neuroendocrine differentiation and secretory proteins in the parenchyma in hyperplasia and in carcinoma of the prostate. Studentlitteratur Malmö, Universität Lund
Abrahamsson PA, Wadström LB, Alumeter J, Falkmer S, Grimelius L (1986) Peptide-hor—mone and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 181:675–683
Abrahamsson PA, Wadström LB, Alumeter J, Falkmer S, Grimellus L (1987) Peptide-hor—mone and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Pathol Res Pract 182:298–307
Accetta PA, Gardner WA, Jr (1982) Squamous metastases from prostatic adenocarcinoma. Lab Invest 46:2 A
Achtstätter Th, Moll R, Moore B, Franke WW (1985) Cytokeratin polypeptide patterns of different epitheHa of the human male urogenital tract : Immunofluorescence and gel elec—trophoretic studies. J Histochem Cytochem 33:415–425
Ahluwaha B, Jackson MA, Jones GW, Wilhams AO, Rao MS, Rajguru S (1981) Blood hormones profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 48:2267–2273
Akazaki K (1973) Comparative studies on the prevalence of latent prostate cancer among Japanese, American and Colombian males. Director’s report 1968/69. Aichi Cancer Center Research Institute, Nagoya
Akazaki K, Stemmermann GN (1973) Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 50:1137–1144
Aiken CE, Dhom G, Kopper B, Rehker H, Dietz R, Kopper S, Ziegler M (1977) Verlaufskontrolle nach Hochvolt-Therapie des Prostatakarzinoms. Urologe [A] 16:272–278
Almagro VA (1985) Argyrophihc prostatic carcinoma. Case report with literature review on prostatic carcinoid and „carcinoid-hke” prostatic carcinoma. Cancer 55:608–614
Altenähr E, Kastendieck H (1980) Proliferative patterns in prostatic carcinoma. In: Spring-Mills E, Hafez ESE (eds) Male accessory sex glands. Elsevier/North-Holland Biomedical
Altmannsberger M (1988) Intermediärfilamentproteine als Tumormarker in der Tumordiagnostik. Heft 127. Veröffentl Pathol. Fischer, Stuttgart
Altmannsberger M, Osborn M, Weber K, Schauer A (1982) Expression of intermediate filaments in different human epithehal and mesenchymal tumors. Pathol Res Pract 175: 227–237
Andrews GS (1951) The histology of the human foetal prepuberal prostates. J Anat 85:44–55
Ansari MA, Pintozzi RL, Choy YS, Ladove RF (1981) Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method. Am J Clin Pathol 76:94–98
Armenian HK, Lihenfeld AM, Diamond EL, Bross JD (1974) Relationship between benign prostatic hyperplasia and cancer of the prostate. Lancet 2:115–117
Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortahty in different countries, with special reference to dietary practices. Int J Cancer 15:617–631
Attah EB, Nkposong EO (1976) Phyllodes type of atypical prostatic hyperplasia. J Urol 115:762–764
Attah EB, Powell MEA (1977) Atypical stromal hyperplasia of the prostate gland. Am J Clin Pathol 67:324–327
Aumüller G (1973) Über Sialomucinproduzierende Zellen der Prostata. Verh Anat Ges 67: 233–243
Aumüller G (1979) In: Oksche A, Vollrath L (eds) Handbuch der mikroskopischen Anatomie des Menschen. 7. Band, Harn—und Geschlechtsapparat, 6. Teil. Prostate Gland and Seminal Vesicles. Springer, Berlin Heidelberg New York
Aumüller G (1983 a) Morphologie der normalen Prostata und experimentelle Modelle der Prostataforschung. In: Helpap B (ed) Prostatahyperplasie, pmi, Frankfurt, S15–30
Aumüller G (1983 b) Morphologie and endocrine aspects of prostatic function. Prostate 4:195–214
Aumüller G (1984) Immunzytochemie beim Prostatacarcinom. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Die Prostata Bd. 2. Prostatacarcinom, pmi, Frankfurt, S165
Aumüller G, Pohl C, van Etten RL, Seitz J (1981) Immunohistochemistry of acid phosphatase in the human prostate: Normal and pathologic cytochemistry and biochemistry of acid phosphatase II. Virchows Arch [B] 35:249–262
Azumi N, Shibuy H, Ishikura M (1984) Primary prostatic carcinoid tumor with intracyto—plasmatic prostatic acid phosphatase and prostate-specific antigen. Am J Surg Pathol 8: 545–549
Azzopardi JG, Evans DJ (1971) Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium. J Pathol 104:247–251
Baker LH, Mebust WK, Chin TD Y et al. (1981) The relationship of herpes virus to carcinoma of the prostate. J Urol 125:370–374
Bangert V (1971) Untersuchungen zur postnatalen Chemodifferenzierung der Prostata des Menschen. Med. Dissertation Mainz
Barrett DM, Kelalis PP (1976) Retroperitoneal tumors and related disorders. In: Kelahs PP, Kind LR (eds) Clinical pediatric urology. Saunders, Philadelphia
Barringer BS (1933) Papillary intracystic adenocarcinoma of prostate and massive benign prostatic cyst. Am J Surg 20:51
Bartsch F, Frick J, Rüegg J, Bucher M, Holliger O, Oberholzer M, Rohr HP (1979 a) Electron microscopic stereological analysis of the normal human prostate and benign prostate hyperplasia. J Urol 122:481–486
Bartsch G, Müller HR, Oberholzer M, Rohr HP (1979 b) Lightmicroscopic stereological analysis of the normal human prostate and of benign prostate hyperplasia. J Urol 122: 487–491
Batson OV (1942) The role of the vertebral veins in metastatic processes. Ann Intern Med 16:38–45
Battagha S, Barbolini G, Botticelh AR (1979) Early (stage A) prostatic cancer. Virchows Arch [A] 382:245–259
Beahrs OH, Myers MH (eds) (1983) Manual for staging of cancer. Lippincott, Philadelphia
Bean MA, Yatani R, Liu PJ, Fukazawa K, Ashley W, Fujita Sh (1973) Prostatic carcinoma at autopsy in Hiroshima and Nagasaki Japanese. Cancer 32:498–506
Becker N, Frentzel-Beyme R, Wagner G (1984) Krebsatlas der Bundesrepublik Deutschland, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo
Berg JW (1975) Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res 35:3345–3350
Berlie J, Rezvani A, Hacene K, Bastien H, Chauvergne J, Guerrin J, Le Commandeur J, Brunet M (1985) Cancer de la prostate, bilan épidémiologique, fréquence, tendance, en particulier en France. Bull Cancer (Paris) 72:391–404
Berry NE, Reese L (1953) Malignant melanoma which had its first chnical manifestations in the prostate gland. J Urol 69:286–290
Berry StJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479
Bier B, Seitz G, Wernert N, Dhom G (1988) Differenzierungswandel von Prostatacarcinomen unter Androgenentzug. Verh Dtsch Ges Pathol 72:602
Bleichner C, Chun B, Klappenbach R (1980) Pure small cell carcinoma of the prostate with fatal liver metastasis. Arch Pathol Lab Med 110:1041–1044
Block NL, Weber D, Schinella R (1972) Blue nevi and other melanocytic lesions of the prostate: Report of 3 cases and review of the Uterature. J Urol 107:85–87
Böeking A (1981) Reproduzierbares zytologisches Mahgnitätsgrading des Prostatakarzinoms. Akt Urol 12:278–282
Boeking A, Sommerkamp H (1980) Histologisches Mahgnitätsgrading des Prostatakarzinoms. Verh Dtsch Ges Urol 32:63–65
Böeking A, Sinagowitz E (1980) Histologic grading of prostatic carcinoma. Path Res Pract 168:115–125
Böeking A, Kiehn J, Heinzel-Wach M (1982) Combined histologic grading of prostatic carcinoma. Cancer 50:288–294
Böeking A, Helpap B, Kastendieck H, Müller HA (1984) Zytologisches Regressions grading des Prostatakarzinoms. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Prostatakarzinom. pmi, Frankfurt
Boing H, Martinez L, Frentzel-Beyme R, Oltersdorf V (1985) Regional nutritional pattern and cancer mortahty in the Federal Republic of Germany. Nutr Cancer 7:121–130
Bonkhoff H, Wernert N, Remberger K, Dhom G (1989) Topographische Lagebeziehung zwischen endokrin differenzierten Zellen und der Proliferationsfraktion in Prostatakarzinomen. Verh Dtsch Ges Pathol 73 (in Druck)
Bostwick DG, Brawer MK (1987) Prostatic intraepithehal neoplasia and early invasion in prostate cancer. Cancer 59:788–794
Brandes D, Groth DP, Györkey F (1962) Occurrence of lysosomes in the prostatic epithe-Hum of castrate rats. Exp Cell Res 28:61–68
Brandes D, Kirchheim D, Scott W (1964) Ultrastructure of the human prostate. Lab Invest 13:1541–1560
Brawer MK, Peehl DM, Stamey ThA, Bostwick DG (1985) Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45:3663–3667
Brawn PN (1982) Adenosis of the prostate. Cancer 49:826–833
Brawn PN, Johnson ChF (1987) The metastatic potential of prostate carcinomas composed entirely of single malignant glands. Virchows Arch [A] 411:399–402
Breslow N, Chan CW, Dhom G, Drury AB, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977) Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20:680–688
Bridges CH, Belville WD, Insalaco SJ, Buck AS (1983) Stage A prostatic carcinoma and repeated transurethral resection: A reappraisal 5 years later. J Urol 129:307
Brinkmann B (1988) Structure of the androgen receptor. 6. Cansteiner Colloquium. Neue Aspekte zur Regulation der Prostatafunktion. Schloß Canstein, 16.-18.6. 1988 (in press)
Broders AC (1926) Carcinoma, grading and practical apphcation. Arch Pathol 2:376–381
Brooks B, Miller GJ (1986) Evaluation of prostatic cancer histology and grade distribution: Experience with the Colorado Central Cancer Registry. Prostate 8:139–150
Bruce AW, Trachtenberg J (eds) (1987) Adenocarcinoma of the prostate. Springer, Berlin Heidelberg New York Tokyo
Bülow H, Wullstein HK, Böttger G, Schröder FH (1973) Mamma-Carcinom bei oestrogenbehandeltem Prostata-Carcinom. Urologe [A] 12:249–253
Burckhardt R, Frisch B, Sommerfeld W, Binsack Th, Kettner G (1982) Der Wert der Kno—chenmarkbiopsien zur Erkennung der Metastasierung. Verh Dtsch Krebsges 3:373–387
Butler JJ, Howe CD, Johnson DE (1971) Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma. Cancer 27:1055–1063
Butterick JD, Schnitzer B, Abell MR (1971) Ectopic prostatic tissue in urethra: a clinicopathological entity and a significant cause of hematuria. J Urol 105:97
Buttyan R, Sawczuk JS, Benson MC, Siegal JD, Olsson CA (1987) Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11:327–337
Byar DP (1987) Incidence, mortality and survival statistics for prostate cancer. In: Current Concepts and approaches to the study of prostate cancer. Liss, New York
Cantrell BB, DeKlerk DP, Eggleston C, Boitnott JK, Walsh PC (1981) Pathological factors that influence prognosis in stage A prostatic cancer: The influence of extent versus grade. J Urol 125:516–520
Capella C, Usellini L, Buffa R, Frigerio B, Solcia E (1981) The endocrine component of prostatic carcinomas, mixed adenocarcinoma-carcinoid tumors and nontumor prostate. Histochemical and ultrachemical identification of the endocrine cells. Histopathology 5: 175–192
Caselitz J, Walther B, Wustrow J, Seifert G, Weber K, Osborn M (1986) A monoclonal antibody that detects myoepithehal cells in exocrine glands, basal cells in other epithehal and basal and suprabasal cells in certain hyperplastic tissues. Virchows Arch [A] 409:725–738
Castaldo JE, Bernat JC, Meier FA, Schned AR (1983) Intracranial metastases due to prostatic carcinoma. Cancer 52:1739–1747
Catalona WJ (1984) Prostate cancer. Grune & Stratton, Orlando San Diego San Francisco New York
Catane R, Kaufman J, Wesh CS, Merrin CL, Tsukuda Y, Murphy GP (1976) Brain metastasis from prostatic carcinoma. Cancer 38:2583–2587
Centifano YM, Kaufman HE, Zam ZS (1973) Herpes virus particles in prostatic cancer cells. J Virol 12:1608–1611
Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Eng BS, Meunier PJ (1983) Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia. Cancer 51:918–924
Chibber PJ, Mclntyre MA, Hindmarsh JR, Hargreave TB, Newsam JE, Chisholm GD (1981) Transitional cell carcinoma involving the prostate. Br J Urol 53:605–609
Choudhury M, DeRosas J, Papsidero L (1982) Metastatic prostatic carcinoma to breast or primary breast carcinoma. Urology 19:297–299
Clark TD, Askin FB, Baguell ChB (1987) Nuclear roundness factor: A quantitative approach to grading in prostatic carcinoma, rehability of needle biopsy tissue, and the effect of tumor stage on usefulness. Prostate 10:199–206
Cleary KR, Choi HY, Ayala AG (1983) Basal cell-hyperplasia of the prostate. Am J Clin Pathol 80:850–854
Coppola RJ, Salanga VD (1980) Metastatic prostatic adenocarcinoma to temporal bone. Neurology 30:311
Cox R, Dawson MP (1960) A curious prostatic tumour:Probably a true mixed tumour (cystadeno-leiomyo-fibroma). Br J Urol 32:306–311
Cuatico W, Cheung CH, Sy F (1978) Detection of viral-like cores from the urine of patients with genitourinary mahgnancies. Cancer 41:706–711
Czernobilsky B (1985) Co-expression of cytokeratin and vimentin filaments in mesothehal, granulosa and rete ovarii cells of the human ovary. Eur J Cell Biol 37:175–190
Dauge MC, Grossin M, Doumecq-Lacoste JM, Vinceneux PS, Delmas V, Bocquet L (1985) Tumeur „carcinoid” de la prostate. Une nouvelle observation anatomochnique avec revue de la littérature. Arch Anat Cytol Pathol 33:73–79
Deklerk DP, Scott WW (1978) Prostatic maldevelopment in the prune-belly-syndrome: A defect in prostatic stromal-epitheHal interaction. J Urol 120:341–344
Deklerk DP, Coffey DS, Ewing LL, McDermott JR, Reiner WG, Robinson CH, Scott WW, Standberg JD, Talakay P, Walsh PC, Wheaton LG, Zirkin BR (1979) A comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 64: 842–848
Devine ChJ, Gonzalez-Serva L, Stecker JF, Devine PC, Horton ChE (1980) Utricular configuration in hypospadia and intersex. J Urol 123:407–411
Dhom G (1974) Differentialdiagnostische Probleme des Prostatakarzinoms. Erfahrungen mit dem Prostatakarzinom-Register. Beitr Pathol 153:203–220
Dhom G (1977) Classification and grading of prostatic carcinoma. In: Grundmann E, Vahlensieck W (eds) Tumors of the male genital system. Ree Results Cancer Res 60: 14–26
Dhom G (1978) Das Prostatakarzinom und die Bedeutung seiner Früherkennung. Med uns Zeit 2:134–142
Dhom G (1979) Frühe neoplastische Veränderungen der Prostata. Verh Dtsch Ges Pathol 63:218–231
Dhom G (1983 a) Erkrankungen der Prostata. In: Frommhold W, Gerhardt P (Hrsg) Klinisch-radiologisches Seminar, Ed 13. Thieme, Stuttgart New York
Dhom G (1983 b) Epidemiologie aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol 106:210–218
Dhom G (1984) Immunhistochemische Befunde beim unbehandelten und beim behandelten Prostatacarcinom. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Die Prostata Bd 2. Prostatacarcinom. pmi, Frankfurt, S 320
Dhom G (1985) Histopathology of prostate carcinoma. Path Res Pract 179:277–303
Dhom G (1988) Incipient prostate cancer: Definition, histology and clinical consequences. Ree Results Cancer Res 106:85–93
Dhom G, Bier B (1987) Die Lymphknotenschnellschnittuntersuchung bei urologischen Tumoren. Verh Dtsch Ges Urol 38:13–17
Dhom G, Degro S (1982) Therapy of prostatic cancer and histopathologic follow-up. Prostate 3:531–542
Diamond DA, Berry StJ, Jewett HJ, Eggleston JC, Coffey DS (1982) A new method to assess metastatic potential of human prostate cancer& Relative nuclear roundness. J Urol 128:729–734
Dikman SH, Toker C (1973) Seromucinous gland ectopia within the prostatic stroma. J Urol 109:852–853
Di Sant’Agnese PA, de Mesy Jensen KL (1984 a) Somatostatin and/or somatostatin-like immunoreactive endocrine-paracrine cells in the human prostate gland. Arch Pathol Lab Med 108: 693–696
Di Sant’Agnese PA, de Mesy Jensen KL (1984 b) Endocrine-paracrine cells of the prostate and prostatic urethra:An ultrastructural study. Hum Pathol 15:1034–1041
Di Sant’Agnese PA, de Mesy Jensen KL, Churukian CJ, Agarwal MM (1985) Human prostatic endocrine-paracrine (APUD) cells. Arch Pathol Lab Med 109:607–612
Di Sant’Agnese PA, Jensen M (1987) Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol 18:849–856
Döring L (1975) Metastasis of carcinoma of prostate to meningioma. Virchows Arch [A] 366: 97–91
Donn AS, Muir CS (1985) Prostatic cancer. Some epidemiologic features. Bull Cancer (Paris) 72:381–390
Donohue RE, Fauver HE, Whitesel JA, Augspurger RR, Pfister RR (1981) Prostatic carcinoma: Influence of tumor grade on results of pelvic lymphadenectomy. Urology 17:435–440
Drach GW, Kohnen PW (1977) Prostatitis. In: Tannenbaum M (ed) Urologie Pathology:The prostate. Lea & Fibiger, Philadelphia
Dreyfuss ML, Simon S, Sommer RJ (1961) Granulomatous prostatitis due to cryptococcus neoformans (torula) with disseminated cryptococcosis and meningitis. NY State J Med 61:1589
Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409
Eder M (1984) Die Metastasierung: Fakten und Probleme aus humanpathologischer Sicht. Verh Dtsch Ges Pathol 68:1–11
Edwards CN, Steinthorsson E, Nicholson D (1953) An autopsy study of latent carcinoma. Cancer 6:531–554
Ekfors TO, Aho JH, Kekomäki M (1985) Malignant rhaboid tumor of the prostatic origin.Virchows Arch Path Anat 406:381–388
Ekman P, Snochowski M, Dahlberg E, Gustafsson JA (1979) Steroid receptors in metastatic carcinoma of the human prostate. Eur J Cancer 15:257–262
Elder JS, Gibbons RP, Correa RJ, Brannen GE (1985) Efficacy of radical prostatectomy for stage A 2 carcinoma of the prostate. Cancer 56:2151–2154
Ellis DW, Leffers J, Baries JS, Ng ABR (1984) Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol 81:279–284
Ende N, Woods LP, Shelley HS (1963) Carcinoma originating in ducts surrounding the prostatic urethra. Am J Clin Pathol 40:183–189
Epstein JI, Berry STJ, Eggleston JC (1984) Nuclear roundness factor. A predictor of progression in untreated stage A 2 prostate cancer. Cancer 54:1666–1671
Epstein NA (1977) Primary papillary carcinoma of the prostate. Report of a histopathologic, cytologic and electron microscopic study on one case. Acta Cytol 21:543–546
Epstein NA, Fatti LP (1976) Prostatic carcinoma. Some morphological features affecting prognosis. Cancer 37:2455–2465
Ernster VL, Seluin S, Sacks ST, Austin DF, Brown SM, Winkelstein W (1978) Prostatic cancer: Mortahty and incidence rates by race and social class. Am J Epidemiol 107:311–320
Esposti PL (1971) Cytologic mahgnancy grading of prostatic carcinoma by transrectal aspiration biopsy: A five year follow-up of 469 hormone treated patients. Scand J Pathol Nephrol 5:199–209
Evans N, Branes RW, Brown AF (1942) Carcinoma of the prostate. Correlation between the histologic observations and the clinical course. Arch Pathol 34:473–483
Fair WR, Sharer W (1986) Prostatitis. In: Blandy JP, Lytton B (eds) The Prostate. Butterworth, London Boston Durban Singapore Sydney Toronto Welhngton
Faul P, Eisenberger F, Elsässer E (1985) Metastatischer Befall pelviner Lymphknoten in Abhängigkeit vom morphologischen Differenzierungsgrad und klinischen Stadium des Prostatakarzinoms. Urologe [A] 24:326–329
Fetissof F, Dubois MP, Arbeille-Brassart B, Lauson Y, Boivin F, Jobard P (1983) Endocrine cells in the prostate glands, urothehum and Brenner tumors. Virchows Arch Cell Pathol 42:53–64
Fetissof F, Bonandet P, Arbeille B (1988) Calcitonin-secreting carcinomas of the prostate. An immunohistochemical and ultrastructural analysis. Am J Surg Pathol 10:702–710
Feustel A, Wennrich R, Steiniger D, Klauss P (1982) Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH). Urol Res 10:301–303
Feyrter F (1951 a) Zur Pathologie des urogenitalen Helle-Zellen-Systems. Virchows Arch 320:564–576
Feyrter F (1951b) Über das urogenitale Helle-Zellen-System des Menschen. Mikr Anat Forsch 57:324–344
Fisher ER, Jeffrey W (1965) Ultrastructure of human normal and neoplastic prostate. With comments relative to prostatic effects of hormonal stimulation in the rabbit. Am J Chn Pathol 44:119–134
Flanders WD (1984) Review: Prostate cancer epidemiology. Prostate 5:621–629
Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettiger NM, Johnston B, Dodd JG, Matusik RJ (1986) Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res 46:1535–1538
Föllinger S (1987) Probleme der histopathologischen Bestimmung des Malignitätsgrades differenzierter Prostatakarzinome. Dissertation, Homburg/Saar
Ford TF, Butcher ND, Masters JR, Parkinson C (1985) Immunocytochemical localization of prostate-specific antigen: Specifity and apphcation to chnical practice. Br J Urol 57:50–55
Fox M (1963) The natural history and significance of stone-formation in the prostate gland. J Urol 89:716–727
Franke WW, Grund Ch, Jackson BW, Illmensee K (1983) Formation of cytoskeletal elements during mouse embryogenesis. IV. Ultrastructure of primary mesenchymal cells and their cell-cell interactions. Differentiation 25:121–141
Frankel K, Craig JR (1974) Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 62:639–645
Franks LM (1954 a) Atrophy and hyperplasia in the prostate proper. J Pathol Bact 68:617–621
Franks LM (1954 b) Benign nodular hyperplasia of the prostate: A review. Ann Roy Coll Surg Engl 14:92–106
Franks LM (1960) Estrogen-treated prostatic cancer. The variation of responsiveness of tumor cells. Cancer 13:490–501
Franks LM (1983) Origins of benign prostatic hypertrophy. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, New York Heidelberg Berlin
Franks LM, Chesterman FC (1956) Intraepithelial carcinoma of prostatic urethra, periurethral glands and prostatic ducts (Bowen’s disease of the urinary epithehum). Br J Cancer 10:223–225
Franks LM, Fergusson JD, Murnaghan GF (1958) Assessment of factors influencing survival in prostatic cancer: Absence of rehable prognostic features. Br J Cancer 12:321–326
Franks LM, O’Shea JD, Thomson AER (1964) Mucin in the prostate: A histochemical study in normal glands, latent, clinical and colloid cancers. Cancer 17:983–991
Furusato M, Mostofi FK (1980) Intraprostatic lymphatics in man. Light and ultrastructural observations. Prostate 1:15–23
Gaeta JF (1981) Glandular profiles and cellular patterns in prostatic cancer grading. Urology 17 [Suppl]: 33–37
Gaeta JF, Asirwatham JE, Miller G, Murphy GP (1980) Histologic grading of primary prostatic cancer: A new approach to an old problem. J Urol 123:689–693
Garfinkel L (1986) Overweight and mortality. Cancer 58:1826–1829
Gaynor EP (1938) Zur Frage des Prostatakrebses. Virchows Arch [A] 301:602–656
Ghali VS, Garcia RL (1984) Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature. Cancer 54:1043–1048
Ghanadian R, Puah CM, O’Donohue EPN (1979) Serumtestosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer 39:696–699
Ghandur-Mnaymneh L, Satterfield S, Block NL (1986) Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion. Morphological immunohistochemical and clinical expressions. J Urol 135:1263–1266
Ghazizadeh M, Kagawa S, Takigawa H, Kurokawa K, Numoto S (1983) Specific red cell adherence test in benign and mahgnant lesions of the prostate. Br J Urol 55:405–407
Ghazizadeh M, Kagawa S, Izumi K, Maebayashi K, Takigawa H, Saiki T, Kawano A, Kurokawa K (1984) Immunohistochemical detection of carcinoembryonic antigen in benign hyperplasia and adenocarcinoma of the prostate with monoclonal antibody. J Urol 131: 501–503
Gilmour AM, Bell TJ (1986) Adenoid cystic carcinoma of the prostate. Br J Urol 58:105—106
Glantz GM (1964) Cirrhosis of carcinoma of the prostate gland. J Urol 93:287–295
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125–128
Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologie pathology: The prostate. Lea & Fibiger, Philadelphia
Gleason DF (1985) Atypical hyperplasia, benign hyperplasia and well-differentiated adenocarcinoma of the prostate. Am J Surg Pathol 9:53–67
Glenister TW (1962) The development of the utricle and of the so-called „middle” or „median” lobe of the human prostate. J Anat 96:443–455
Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the normative aging study. Am J Epidemiol 121: 78–90
Goebbels R, Amberger L, Wernert N, Dhom G (1985) Urothelial carcinoma of the prostate. Appl Pathol 3:242–254
Gögl H, Lang FJ (1957) Geschlechtsorgane. In: Staemmler M (ed) Lehrbuch der Speziellen Pathologischen Anatomie. II. Bd, 1. Teil, de Gruyter, Berlin
Golimbu M, Morales P (1979) Stage A 2 prostatic carcinoma. Should staging system be reclassified? Urology 18:592–596
Gordon HL, Miller DH, Rawls WE (1972) Viral studies in patients with nonspecific prostato-urethritis. J Urol 108:299–300
Gown AM, Vogel AM (1984) Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol 114:309–321
Graham S, Haughey B, Marshall J, Priore R, Byars T, Rzepka T, Metthn C, Pontes JE (1983) Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 70: 687–692
Greenwald P, Kirmss V, Polan AK, Dick VS (1974) Cancer of the prostate among men with benign prostate hyperplasia. J Natl Cancer Inst 53:335–340
Gritti EJ, Cook FE, Spencer HE (1963) Coccidioidomykosis Granuloma of the prostate: A rare manifestation of the disseminated disease. J Urol 89:249–252
Gueft B, Walsh MA (1975) Mahgnant prostatic cystosarcoma phyllodes. NY State J Med 75:2226–2228
Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P (1980) Prevalence of latent prostate carcinoma in two US populations. J Natl Cancer Inst 65:311–316
Gutierrez J, Nesbit RM (1967) Ectopic prostatic tissue in bladder. J Urol 98:474
Habenicht VF, El Etreby MF (1988) The periurethral zone of the prostate of the cynomol—gus monkey is the most sensitive prostate part for an estrogenic stimulus. Prostate 13: 305–316
Haddad JR, Reyes EC (1970) Carcinosarcoma of the prostate with metastasis of both elements& Case report. J Urol 103:80–83
Haenszel W, Kurihura M (1968) Studies of Japanese migrants. 1. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43–68
Hakulinen T, Andersen AA, Malker B, Pukkala E, Schon G, Tuhnius H (1986) Trends in cancer incidence in the Nordic countries. The Nordic Cancer Registries. Munksgaard, Copenhagen
Hamlin WB, Lund PK (1967) Carcinosarcoma of the prostate: A case report. J Urol 97:518–522
Hamperl H (1952) Über argyrophile Zellen. Virchows Arch 321:482–507
Hansemann D, von (1903) Uber Malakoplakie der Harnblase. Virchows Arch [A] 173:302–308
Harada M, Mostofi FK, Corle DK, Byar DP, Trump BF (1977) Preliminary studies of histologic prognosis in cancer of the prostate. Cancer Treat Rep 61:223–225
Haroske G, Kemmer C, Zotter ST, Lohse R (1979) Ein Fall von Malakoplakie der Prostata. Zentralbl Allg Pathol 123:365–371
Heising J, Cremer H, Davidts H (1985) Das maligne fibröse Histiocytom der Prostatakapsel. Urologe [A] 24:118–121
Heller J, Sprinz O (1921) Beiträge zur vergleichenden und pathologischen Anatomie des Colliculus seminalis. Z Urol Chir 7:196–258
Helminen HJ, Ericcson JLE (1971) Ultrastructural studies on prostatic involution in the rat. J Ultrastruct Res 36:708–724
Helpap B (1980) The biological significance of atypical hyperplasia of the prostate. Virchows Arch [A] 387:307–317
Helpap B (1981) Cell kinetic and cytological grading of prostatic carcinoma. Virchows Arch [A] 393:205–214
Helpap B (1982) Zur Morphologie des Prostatakarzinoms. Extr Urol 5:491–517
Helpap B (1983) Praeneoplasien der Prostata. Extr Urol 6:287–317
Helpap B, Otten J (1982) Histologisch-cytologisches Grading von uniformen und pluriformen Prostatakarzinomen. Pathologe 3:216–222
Helpap B, Stiens R (1975) The cell proliferation of epithehal metaplasia in the prostate gland. Virchows Arch [B] 19:69–76
Helpap B, Vogel J (1986) TUR-Prostatitis. Histological and immunohistochemical observations on a special type of granulomatous prostatitis. Pathol Res Pract 181:301–307
Helpap B, Boeking A, Dhom G, Faul P, Kastendieck H, Leistenschneider W, Müller HA (1985) Klassifikation, histologisches und cytologisches Grading sowie Regressionsgra—ding des Prostatakarzinoms. Pathologe 6:3–7
Herbert JT, Birkhoff JD, Feorino PH (1976) Herpes simplex virus type 2 and cancer of the prostate. J Urol 116:611–612
Hermanek P (1986) Neue TNM/pTNM-Klassifikation und Stadieneinteilung urologischer Tumoren ab 1987. Urologe [B] 26:193–197
Heshmat MY, Kaul L, Kovi J, Jackson MA, Jackson AG, Jones GW, Edson M, Enterline JP, Worrell RG, Perry SL (1985) Nutrition and prostate cancer: A case-control study. Prostate 6:7–17
Hill P, Garbaczewski L (1984) Age, environmental factors and prostatic cancer: Med Hypotheses 14:29–39
Hill P, Wynder EL, Garbaczewski L, Walker ARP (1982) Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer. Cancer Res 42:3864
Hindson JA, Knight LL, Ocker JM (1985) Small cell carcinoma of the prostate: Transient complete remission with chemotherapy. Urology 26:182–184
Hirayama T (1979) Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monogr 53:149–155
Hodge GB, Carson CC (1985) Oat cell carcinoma of the lung masquerading as prostatic carcinoma. Urology 25:69–70
Hodges CV, Wan ShP (1983) The relationship between benign prostatic hyperplasia and prostatic carcinoma. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York
Hohbach CH (1977) Ultrastructural and enzyme-histochemical studies of the prostate of the dog under the effect of estradiol. Beitr Pathol 160:260–273
Hohbach CH (1979) Die funktionelle Cytomorphologie des Drüsenepithels der Prostata-dargestellt an der Prostata des Hundes. Habihtationsschrift Homburg/Saar
Hohbach M, Dhom G (1972) Aktuelle Probleme des Prostatakarzinoms. Münch Med Wo—chenschr 114:45–54
Hohbach CH, Dhom G (1980 a) Pathology of prostatic cancer. Scand J Urol Nephrol [Suppl] 55 37–47
Hohbach CH, Dhom G (1980 b) Die granulomatöse Prostatitis—eine klinische und patho—anatomische Differentialdiagnose des Prostatacarcinoms. Verh Dtsch Ges Pathol 64: 344–349
Holman CDJ, James JR, Segal MR, Armstrong BK (1981) Recent trends in mortality from prostate cancer in male populations of Australia and England and Wales. Br J Cancer 44: 340–348
Holthöfer H, Mietinen A, Lehto VP, Lehtonen E, Virtanen I (1984) Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest 50:552–559
Howard FS (1948) Hypospadias with enlargement of the prostatic utricle. Surg Gynecol Obstet 86:307
Howell MA (1974) Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer 29:328–336
Huben R, Natarajan N, Pontes E, Mettlin C, Smart ChR, Murphy GP (1982) Carcinoma of prostate in men less than fifty years old. Urology 20:585–588
Hubner C (1968) Die Entzündung der hypertrophierten Prostata. Z Urol Nephrol 61:801–804
Huggins C (1967) Endocrine induced regression of cancers. Science 156:1050–1054
Huggins C, Stevens RE, Hodges CV (1941 a) Studies on prostatic cancer. I. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293–297
Huggins C, Stevens RE, Hodges CV (1941 b) Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43:209–223
Immergut M, Flocks RH (1966) Carcinoma of the prostate in patients less than 21 years old. J Urol 95:724–727
Iverson AP, Blackard CE, Schulberg VA (1972) Carcinoma of the prostate with urethral metastases. J Urol 108:901–904
Jacobi GH, Hohenfellner R (1982) Staging, management and post-treatment re-evaluation of prostate cancer: Dogma questioned. In: Jacobi H, Hohenfellner R (eds) Prostate Cancer. Williams & Wilkins, Baltimore London, pp 31–56
Jahresbericht des Saarländischen Krebsregisters (1983)
Jao W, Fretzin DF, Christ ML, Prinz LM (1971) Blue nevus of the prostate gland. Arch Pathol 91:187–191
Jelbart ME, Russel PJ, Russel P, Raghavan D (1988) The biology and management of small cell undifferentiated carcinoma of the prostate. In: Wilhams CJ, Krikorian JG, Green MR, Raghavan D (eds) Textbook of Uncommon Cancer. Wiley & Sons, Chichester New York Brisbane Toronto Singapore, pp 249–262
Jewett HJ (1975) The present status of radical prostatectomy for stages A and B prostatic cancers. Urol Chn N Am 2:105–124
Jöbsis AC, De Vries GP, Anholdt RRH, Sanders GTB (1978) Demonstration of the prostatic origin of metastases. Cancer 41:1788–1793
Jöbsis AC, De Vries GP, Meijer AEFH, Ploem JS (1981) The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry. Histochem 13:961–973
Johnson FP (1920) The later development of the urethra in the male. J Urol 4:447–503
Johnson DE, Hogan JM, Ayala AG (1972) Transitional cell carcinoma of the prostate. Cancer 29: 287–293
Johnson DE, Chalbaud R, Ayala AG (1974) Secondary tumors of the prostate. J Urol 112: 507–508
Kafaudaris PM, Polyzonis MB (1983) Fibroadenoma-like foci in human prostatic nodular hyperplasia. Prostate 4:33–36
Kang F, Chun-Fu P (1983) Predicting the probabihty of bone metastasis through histological grading of prostate carcinoma: A retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen. J Urol 130:708–711
Kaplan GW, O’Connor VJ (1966) The incidence of carcinoma of the prostate in Jews and gentiles. J Am Med Assoc 196:123–124
Karpas ChM, Moumgis B (1969) Primary transitional cell carcinoma of prostate gland: Possible pathogenesis and relationship to reserve cell hyperplasia of prostatic periurethral ducts. J Urol 101:201–205
Kastendieck H (1977) Ultrastrukturpathologie der menschhchen Prostatadrüse. In: Büngeler W, Eder M, Lennert K, Peters G, Sandritter W, Seifert G (Hrsg) Veröffentlichungen aus der Pathologie 106. Fischer, Stuttgart New York
Kastendieck H (1980 a) Morphologie des Prostatakarzinoms in Stanzbiopsien und totalen Prostataektomien. Untersuchungen zur Frage der Relevanz bioptischer Befundaussagen. Pathologe 2:31–43
Kastendieck H (1980 b) Correlations between atypical primary hyperplasia and carcinoma of the prostate. Pathol Res Pract 169:366–387
Kastendieck H (1984) Klassifikation, Morphologie und Pathogenese des inzidenten Prostatakarzinoms. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Prostatakarzinom, pmi, Frankfurt, S133–164
Kastendieck H, Altenähr E (1974) Das Plattenepithelcarcinom der Prostata als Beispiel einer Tumormetaplasie. Z Krebsforsch 82:335–340
Kastendieck H, Altenähr E (1975) Morphogenese und Bedeutung von Plattenepithelmetaplasien in der menschhchen Prostata. Virchows Arch [A] 365:137–150
Kastendieck H, Altenähr E (1976) Cyto—and histomorphogenesis of the prostate carcinoma. Virchows Arch [A] 370:207–224
Kastendieck H, Hüsselmann H (1982) Postoperative pathomorphologische Klassifikation des Prostatacarcinoms. Pathologe 3:278–286
Kastendieck H, Altenähr E, Burchardt P (1973) Elektronenmikroskopische Untersuchungen zur Zelldifferenzierung in Prostatakarzinomen. Virchows Arch [A] 361:241–256
Kastendieck H, Altenähr E, Burchardt P (1974 a) Zur Ultrastruktur der Tumor-Stromabeziehungen im Prostatakarzinom. Z Krebsforsch 81:85–100
Kastendieck H, Altenähr E, Geister H (1974 b) Das Myosarkom der Prostata. Dtsch Med Wochenschr 99:392–398
Kastendieck H, Bressel M, Henke A, Htisselmann H (1980) Häufigkeit regionärer Lymphknotenmetastasen beim operablen Prostatakarzinom. Dtsch Med Wochenschr 105:1348–1354
Kaufmann E (1922) Lehrbuch der Speziellen Pathologischen Anatomie, 2. Bd, 7. u. 8. Aufl. Gruyter, Berlin Leipzig
Kazzaz BA (1974) Argentaffin and argyrophil cells in the prostate. J Pathol 112:189–193
Kelalis PP, Greene FK, Weed LA (1962) Brucellosis of the urogenital tract: A mimic of tuberculosis. J Urol 88:347–353
Kelalis PP, Greene LF, Harrison EG (1965) Granulomatous prostatitis: a mimic of carcinoma of the prostate. JAMA 191:287
Kelalis PP, Harrison EG, Utz DC (1966) Allergic granulomas of the prostate: Treatment with steroids. J Urol 96:573–577
Kelalis PP, Harrison EG, Greene LF (1984) Allergic granulomas of the prostate in asthmatics. JAMA 188: 963
Kielleuthner L (1928) Über ausgedehnte Prostatahöhlenbildung (Vorblase) durch Tuberkulose. Z Urol Chir 24:277–287
King M, Diamond E, Lilienfeld AM (1963) Some epidemiological aspects of cancer of the prostate. J Chron Dis 16:117–153
Kipling MD, Waterhouse J AH (1967) Cadmium and prostate carcinoma. Lancet 1:730–731
Kirchheim D, Bacon RL (1969) Ultrastructural studies of carcinoma of the human prostate gland. Invest Urol 6:611–630
Kirchheim D, Niles NR, Frankus E, Hodges CV (1966) Correlative histochemical and histological studies on thirty radical prostatectomy specimens. Cancer 19:1683–1696
Kirdani R, Pontes E, Murphy G, Sandberg A (1984) Correlation of estrogen and androgen receptor status in prostatic disease measured by high pressure liquid chromatography. J Steroid Biochem 20:401–406
Klein H, Bressel M, Kastendieck H, Voigt KD (1988) Adrenale Androgenvorstufen, Steroidmetabolismus und Androgenanreicherung im unbehandelten Prostatacarcinom. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Prostataerkrankungen, pmi, Frankfurt, S193–200
Klein PJ, Vierbuchen M, Fischer J, Schulz KD, Farrar G, Uhlenbruck G (1983) The significance of lectin receptors for the evaluation of hormone dependence in breast cancer. J Steroid Biochem 19:839–844
Koenig CJ, De Villiers DM (1968) Prostatic carcinoma in a Bantu-child. S Afr Med J 42: 589–590
Kolonel L, Winkelstein W (1977) Cadmium and prostatic cancer. Lancet 2:566–567
Kolonel LN, Nomura AMY, Hinds MW, Hirobata T, Hankin JH, Lee M (1983) Role of diet in cancer incidence in Hawaii. Cancer Res [Suppl] 43:2397–2402
Kopper B, Dhom G, Mast G, Konrad G, Ziegler M (1983) Staging des „incidental carcinoma” der Prostata durch diagnostische transurethrale Nachresektion. Akt Urol 14:277–280
Kopper B, Dhom G, Schwaiger R, Neisius D, Ziegler M (1986) Erfahrungen mit der pelvinen Lymphadenektomie beim Prostatakarzinom. Akt Urol 17:129–133
Kovi J, Jackson MA, Rao MS, Heshmat MY, Akberzie ME, Williams AO, Christian EC (1982) Cancer of the prostate and aging: An autopsy study in black men from Washington, D. C., and selected African cities. Prostate 3:73–80
Kovi J, Mostofi FK, Heshmat MY, Enterhne JP (1988) Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer 61:551–561
Kozak J, Bartsch W, Krieg M, Voigt KD (1982) Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia. Prostate 3:433–438
Krain LS (1974) Some epidemiologic variables in prostatic carcinoma in California. Prev Med 3:154–159
Kramer SA, Bredael JJ, Krueger RP (1978) Adenoid cystic carcinoma of the prostate: Report of a case. J Urol 120:383–384
Kühn R, Schrott KM (1986) Müller’sche Gangzysten. Urologe [A] 25:124–127
Kuhajda FP, Mann RG (1984) Adenoid-cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen. Am J Clin Pathol 81:257–260
Kyprianou N, Davies P (1986) Association states of androgen receptors in nuclei of human benign hypertrophic prostate. Prostate 8:363–380
Labhart A (1986) The testis. In: Labhart A (ed) Chnical Endocrinology, 5/7. Springer, Berlin Heidelberg New York Tokyo
Lämmel A, Krieg M, Klötzl G (1983) Fluorescein—Are conjugated androgens appropriate for a histochemical detection of prostatic androgen receptors? Prostate 4:271–282
Lämmel A, Krieg M, Klosterhalfen H, Bressel M, Voigt KD (1986) Bestimmung von Ste—roidrezeptoren im Prostatakarzinom: Möghchkeiten und Grenzen. Urologe [A] 25:59–62
Lane EB, Hogan BLM, Kurkinen M, Garrels JI (1983) Coexpression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature 303:701–704
Langley JW, Weitzner ST (1974) Blue nevus and melanosis of prostate. J Urol 112:359–361
LaRocca PJ, Rheinwald JG (1984) Co-expression of simple epithehal keratins and vimentin by human mesothehum and mesothelioma in vivo and in culture. Cancer Res 44:2991–2999
Leav J, Morfin RF, Ofner P, Cavazos LF, Leeds EB (1971) Estrogen and castration-induced effects on canine prostatic fine structure and C-19-steroid metabolism. Endocrinology 89: 465–483
Lee F, Gray JM, McLeary RD, McHugh TA, Solomon MH, Kumasaka GH, Straub WH, Borlaza GS, Murphy GP (1986) Prostatic evaluation by transrectal sonography: Criteria for diagnosis of early carcinoma. Radiology 158:91–95
Lee LW, Burgher LW, Price EB, Cassidy E (1977) Granulomatous prostatitis: Association with isolation of mycobacterium kansasii and mycobacterium fortuitum. JAMA 237: 2408–2409
Lehmann J (1930) Zur Entstehung der Tuberkulose der männlichen Geschlechtsorgane. Virchows Arch 277:537–582
Lehtonen E, Lehto VP, Paasivuo R, Virtanen I (1983) Parietal and visceral endoderm differ in their expression of intermediate filaments. EMBO 2:1023–1028
Leistenschneider W, Nagel R (1979) The cytologic differentiation of prostatitis. Pathol Res Pract 165:429–444
Leistenschneider W, Nagel R (1984) Praxis der Prostatazytologie. Springer, Berlin Heidelberg New York Tokyo
Lemen RA, Lee JS, Wagoner JK (1979) Cancer mortahty among cadmium production workers. Ann NY Acad Sci 271:273–279
Lew EA, Garfinkel L (1979) Variations in mortality by weight among 750000 men and women. J Chron Dis 32:563–579
Liavag J (1967) Carcinoma of the prostate. Universitetsforlaget, Oslo
Lihenfeld AM, Levin ML, Kessler JL (1972) Mortahty and marital status. Cancer in the United States. Harvard Univ Press, Cambridge, pp 123–149
Ljung BM (1988) Flow cytometry and Gleason grades in prostate cancer. In: Karr JP, Coffey DS, Gardner W (eds) Prognostic cytometry and cytopathology of prostate cancer. Elsevier, New York Amsterdam London, pp 233–235
Lou TY, Teplitz C (1974) Malakoplakia: Pathogenesis and ultrastructural morphogenesis. Hum Pathol 5:191–207
Lowsley OS (1912) The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. Am J Anat 13:299–349
Lüleci G, Sakizli M, Giinalp A (1981) Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate and cervix. J Surg Oncol 16:327–331
Lundberg S, Carstensen J, Rundquist J (1987) DNA-flow-cytometry and histopathological grading of paraffinembedded prostate biopsy specimens in a survival study. Cancer Res 47:1973–1977
Lutzeyer W, Hannappel J, Schäfer W (1983) Sequential events in prostatic obstruction. In: Hinman F (ed) Benign prostastic hypertrophy. Springer, Berlin Heidelberg New York, pp 693 ff.
Lynch HT, Larsen AL, Magnuson CW, Krush A J (1966) Prostate carcinoma and multiple primary malignancies; study of a family and 109 consecutive prostate cancer patients. Cancer 19:1891–1897
Lytton B (1983) Interracial incidence of benign prostatic hypertrophy. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York
Lytton B, Emery JM, Harvard BM (1968) The incidence of benign prostatic obstruction. J Urol 99:639–645
Manivel C, Shenoy BV, Wick MR, Dehner LP (1986) Cystosarcoma phyllodes of the prostate. Arch Pathol Lab Med 110:534–538
Mann T (1963) Biochemistry of the prostate gland and its secretion. Natl Cancer Inst Monograph 12:235–251
Manon M, Tananis CE, McLoughlin MG, Walsh PC (1977) Androgen receptors in human prostatic tissue: a review. Cancer Treat Rep 61:265–271
Manrique JJ, Albores-Saavedra J, Orantes A, Brandt H (1978) Malignant mixed tumor of the salivary-gland type, primary in the prostate. Am J Clin Pathol 70:932–937
Mao P, Angrist A (1966) The fine structure of the basal cell of human prostate. Lab Invest 15:1768–1782
Mardh PA, Ripa KT, Colleen S, Trehame JD, Darrugar S (1978) Role of chlamydia trachomatis in nonacute prostatis. Br J Vener Dis 54:330–334
Matsumoto J, Furusato M, Inomata J, Wada T, Aizawa S (1986) Prostatic cancer representing as metastatic adenocarcinoma of the sphenoid sinus. Acta Pathol Jap 36:1753–1756
May P, Hohenfellner R, König E, König K (1966) Diagnostik und Therapie der Prostatatuberkulose. Urol Intern 21:329–337
McCarthy JF, Ritter JS, Klemperer P (1927) Anatomical and histological study of the verumontanum with especial reference to the ejaculatory ducts. J Urol 17:1–16
McClure J (1979) Malakoplakia of the prostate: A report of two cases and a review of the literature. J Clin Pathol 32:629–632
McClure J, Hadden DR, Mudd DG, Parks TG (1977) Adrenocortical hyperactivity with disseminated malakoplakia. J Clin Pathol 30:206–211
McNeal JE (1965) Morphogenesis of prostatic carcinoma. Cancer 18:1659–1666
McNeal JE (1968) Prostate and verumontanum: Regional morphology and pathology of the prostate. Am J Clin Pathol 49:347–357
McNeal JE (1972) The prostate and prostatic urethra: A morphologic synthesis. J Urol 107: 1008–1016
McNeal JE (1978) Origin and evolution of benign prostatic enlargement. Invest Urol 15: 340–345
McNeal JE (1983) Relationship of the origin of benign prostatic hypertrophy to prostatic structure of man and other mammals. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York
McNeal JE (1988) Significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 13: 91–102
McNeal JE, Bostwick DG (1986) Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17:64–71
McNeal JE, Reese JH, Redwine EA, Freiha FS, Stamey TA (1986) Cribriform adenocarcinoma of the prostate. Cancer 58:1714–1719
Meares Jr EM (1973) Bacterial prostatitis vs „prostatosis”. J Am Med Assoc 224:1372–1375
Meares EM (1980) Prostatitis syndromes: New perspectives about old woes. J Urol 123: 141–147
Meares Jr EM (1981) Prostatitis. Kidney Internatl 20:289–298
Meeter VL, Richards JN (1960) Osteogenic sarcoma of the prostate. J Urol 84:654–657
Meikle AW, Stanish WM (1982) Famihal prostatic cancer risk and low testosterone. J Clin Endocrinol Metab 54:1104–1108
Melchior J, Valk WL, Foret JD, Mebust WK (1974) The prostate in leukemia: Evaluation and review of literature. J Urol 111: 647–651
Melicow MM (1951) Allergic granulomas of the prostate gland. J Urol 65:288–296
Mehcow MM, Pachter MR (1967) Endometrial carcinoma of prostatic utricle (utriculus masculinus) Cancer 20:1715–1722
Mehcow MM, Tannenbaum M (1971) Endometrial carcinoma of utriculus mascuHnus (prostatic utricle). Report of six cases. J Urol 106:892–902
Mettlin C (1980) Nutritional habits of blacks and whites. Prev Med 9:601–606
Mettlin C (1983) Cancer of the prostate and testis. In: Bonike GJ (ed) The epidemiology of cancer. Croon Helm, London Sydney, pp 245–259
Metthn C, Natarajan N (1983) Epidemiologic observations from the American college of surgeons survey on prostate cancer. Prostate 4:323–331
Meyer R (1909) Zur Entwicklungsgeschichte und Anatomie des Utriculus prostaticus beim Menschen. Arch Mikr Anat 74:844–854
Michaehs L, Gutmann C (1902) Über Einschlüsse in Blasentumoren. Z KHn Med 47:208–215
Mies C, Balogh K, Stadecker M (1984) Palisading prostate granulomas following surgery. Am J Surg Pathol 8:217–221
Mobbs BG, Connolly JG (1987) Hormone receptors in prostatic cancer. In: Bruce AW, Trachtenberg J (eds) Adenocarcinoma of the prostate. Springer, Berlin Heidelberg New York Tokyo, pp 63–82
Moermann P, Fryns JP, Goddeeris P, Lauweryns JM (1984) Pathogenesis of the prune-belly syndrome: A functional urethral obstruction caused by prostatic hypoplasia. Pediatrics 73:470–475
Moll R, Franke WW, Schiller DL, Geiger G, Krepier R (1982) The catalog of human cyto—keratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11–24
Moll R, Krepier R, Franke WW (1983) Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 23:256–269
Montasser AY, Ong MG, Mehta VT (1979) Carcinoid tumor of the prostate associated with adenocarcinoma. Cancer 44:307–310
Moore M, Halpern LK (1948) Blastomykosis involving the prostate: Report of two cases, one without cutaneous lesions. J Urol 60:612–622
Moore RA (1935) The morphology of small prostatic carcinoma. J Urol 33:224–234
Moore RA (1936) The evaluation and involution of the prostate gland. Am J Pathol 12:599–624
Moore RA (1937 a) Pathology of the prostatic utricle. Arch Pathol 23:517–524
Moore RA (1937 b) Tuberculosis of the prostate gland. J Urol 37:372–384
Morisseau PM, Phillips CA, Leadbetter GW (1970) Viral prostatitis. J Urol 103:767–769
Mostofi FK (1976) Problems of grading carcinoma of prostate. Semin Oncol 3:161–169
Mostofi FK, Price EB (1973) Tumors of the male genital system. Atlas of tumor pathology, 2nd series, fasc 8. Armed Forces Institute of Pathology, Washington
Mostofi FK, Sesterhenn I, Sobin LH (1980) Histological typing of prostate tumours. In: International histological classification of tumours. No. 22. WHO, Geneva
Müller HA, Wünsch PH (1981) Features of prostatic sarcomas in combined aspiration and punch biopsies. Acta Cytol 25:480–484
Müller HA, Altenähr E, Boeking A, Dhom G, Faul P, Göttinger H, Helpap B, Hohbach CH, Kastendieck H, Leistenschneider W (1980) Über Klassifikation und Grading des Prostatakarzinoms. Verh Dtsch Ges Pathol 64:609–611
Muir C, Waterhouse J, Mack T, Powell J, Whelan Sh (1987) Cancer incidence in five continents, vol V. lARC Scientific Publ No. 88, Lyon
Myers GH, Lynn HB, Kelalis PP (1969) Giant cyst of utricle. J Urol 101:369–373
Nadji M, Tabei SZ, Castro A, Ming-Chu T, Morales AR (1980) Prostatic origin of tumors. An immunohistochemical study. Am J Pathol 73:735–739
Nadji M, Tabei SZ, Castro A, Ming-Chu T, Murphy GP, Wang MC, Morales AR (1981) Prostatic specific antigen: An immunohistologic marker for prostatic neoplasms. Cancer 48:1229–1232
Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A (1987) Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47:281–286
National Cancer Institute Report December 1985
Newell GR, Pollack ES, Spitz MR, Sider JG, Fueger JJ (1987) Incidence of prostate cancer and marital status, J Natl Cancer Inst 79:259–262
Newill VA (1961) Distribution of cancer mortaUty among ethnic subgroups of the white population of New York City 1953–1958. J Natl Cancer Inst 26:405–417
Newman AR, Graham MA, Carlton EC, Lieman S (1982) Incidental carcinoma of the prostate at the time of transurethral resection: Importance of evaluating every chip. J Urol 128:948
Nielsen ML, Christensen P (1972) Inflammatory changes of the hyperplastic prostate. Scand J Urol Nephrol 6:6–10
Nielsen ML, Vestergaard F (1973) Virological investigations in chronic prostatitis. J Urol 109:1023–1025
Nigogosyan G, De la Pava S, Pickren JW (1963) Blue nevus of the prostate gland. Cancer 16:1097–1099
Oberndorfer S (1931) Die inneren männhchen Geschlechtsorgane Adenomyome und Myome der Prostata, sog. Prostatahypertrophie. In: Henke F, Lubarsch O (Hrsg) Handbuch der Speziellen Pathologischen Anatomie und Histologie. 6. Band, 3. Teil Männhche Geschlechtsorgane. Springer, Berlin
Okada K, Morita H, Arai R, Kishimoto T (1983) Ultrastructural localization of zinc in the hyperplastic prostate. Prostate 4:631–638
Ortega LG, Whitmore WF, Murphy AJ (1953) In situ carcinoma of the prostate with intra-epithehal extension into the urethra and bladder. Cancer 6:892–923
Paulsen AF, Abrahamsson PA, Bjartell A, Grino M, Hedeland H, Falkmer ST (1988) Carcinoma of the prostate with Cushing’s syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue. In: Abrahamsson PA (ed) Neuroendocrine differentiation and secretory proteins in the parenchyma in hyperplasia and in carcinoma of the prostate. Sweden Studentlitteratur, Universität Lund
Peehl DM, Wehner N, Stamey TA (1987) Activated Ki-ras oncogene in human prostatic adenocarcinoma. Prostate 10:281–289
Pertschuk LP, Zava DT, Gaetjens E, Maccia RJ, Wise GJ, Kim DS, Brigati DJ (1979) Histochemistry of steroid receptors in prostatic diseases. Ann Clin Lab Sci 9:225–229
Phillips RL (1975) Role of life style and dietary habits in risk of cancer among Seventh Day Adventists. Cancer Res 35:3513–3522
Pieterse AS, Aarons I, Jose JS (1984) Focal prostatic granulomas rheumatoid like—probably iatrogenic in origin. Pathology 16:174–177
Polen JJ, Dreilinger A (1984) Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral glands. Urology 23:303–304
Poppel H v, Vereecken R, De Geeter P, Verduyn H (1983) Hemospermia owing to utricularcyst: Embryological summary and surgical review. J Urol 129:608–609
Potts CL (1965) Cadmium proteinuria—The healths of battery workers exposed to cadmium oxide dust. Ann Occup Hyg 8:55–61
Prader A (1986) Disorders of sexual differentiation (intersexuality). In: Labhart A (ed) Clinical endocrinology. Springer, Berlin Heidelberg New York Tokyo, p 715
Pretl K (1944) Zur Frage der Endokrinie der menschlichen Vorsteherdrüse. Virchows Arch [A] 312:392–404
Priesel A (1931) Die Mißbildungen der männhchen Geschlechtsorgane. In: Henke F, Lubarsch O (Hrsg) Handbuch der Speziellen Pathologischen Anatomie und Histologie. 6. Band, 3. Teil Männliche Geschlechtsorgane. Springer, Berlin
Prout GR, Heaney JA, Griffin PP, Daly JJ, Shipley WV (1980) Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol 124:226–231
Randall A (1931) Surgical Pathology of Prostate Obstruction. Wilhams & Wilkins, Baltimore
Randall A, Hinman F (1983) Surgical Anatomy of the Prostatic Lobes. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York
Ravich A, Ravich RA (1951) Prophylaxis of cancer of the prostate, penis and cervix by circumcision. NY J Med 51:1519–1520
Redman JF, Downs RA (1984) Simple eosinophilic granulomatous prostatitis. J Urol 132: 358
Reed RJ (1984) Consultation case. Am J Surg Pathol 8:699–704
Reischauer F (1925) Die Entstehung der sog. Prostatahypertrophie. Virchows Arch 256: 358–389
Reyes JW, Shinozuka H, Garry P, Putong PB (1977) A light and electron microscopic study of a hemangiopericytoma of the prostate with local extension. Cancer 40:1122–1126
Rich AR (1935) On the frequency of occurrence of occult carcinoma of the prostate. J Urol 33:215–223
Riesler CH, Griffin THL (1964) Cysts of the prostate. J Urol 91:282–286
Ro JY, Tetu B, Ayala AG, Ordonez NG (1987) Small cell carcinoma of the prostate. IL Immunohistochemical and electron microscopic studies of 18 cases. Cancer 59: 977–982
Röbel P, Eychenne B, Blondeau JP, Bauheu EE, Hechter O (1985) Sex steroid receptors in normal and hyperplastic human prostate. Prostate 6:255–267
Robson MC (1966) Cirrhosis and prostatic neoplasms. Geriatrics 21:150–154
Rohr HP, Bartsch G (1983) Stereological Analysis. An approach to the pathogenesis of benign prostatic hyperplasia. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York
Rohr HP, Naef HF, Holliger O, Oberholzer M, Ibach B, Weissbach L, Bartsch G (1981) The effect of estrogen and stromal growth of the dog prostate. Urol Res 9:201–207
Rojas-Corona RR, Chen L, Mahadevia PS (1987) Prostatic carcinoma with endocrine features. Am J Clin Pathol 88:759–762
Rose DP (1986) The biochemical epidemiology of prostatic carcinoma. In: Dietary, Fat and Cancer. Liss, New York
Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39:284–292
Ross RK, Deapen DM, Casagrande JT, Paganini-Hill A, Henderson BE (1981) A cohort study of mortality from cancer of the prostate in catholic priests. Br J Cancer 43:233–235
Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE (1987) Case-control studies of prostate cancer in blacks und whites in Southern California. J Natl Cancer Inst 78:869–874
Rotkin JD (1980) Distribution and risk of prostatic cancer. Cancer epidemiology in the USA and USSR. NJH Publ 80:2044, US Governm Printing Office
Rotkin DD (1983) Origins, distribution and risk of benign prostatic hypertrophy. In: Hinman F (ed) Benign Prostatic Hypertrophy. Springer, Berlin Heidelberg New York
Rüdinger N (1883) Der Uterus masculinus. Rieger’sche Universitätsbuchhandlung, Monographie, S1–23
Saarländisches Krebsregister (1988) Morbidität und Mortahtät an bösartigen Neubildungen im Saarland 1986. Sonderheft 143 Statistisches Amt des Saarlandes
Saito R, Davis BK, Ollapally EP (1984) Adenosquamous carcinoma of the prostate. Hum Pathol 15: 87–89
Saitoh H, Hida M, Shimbo T, Nakamura K, Yamagata J, Satoh T (1984) Metastatic patterns of prostatic cancer. Cancer 54:3078–3084
Saltzstein SL, McLaughhn P (1977) Chnicopathologic features of unsuspected regionallymph node metastases in prostatic adenocarcinoma. Cancer 40:1212–1221
Sato A, Spicer SS (1982) Ultrastructural visualization of galactosyl residues in various ah—mentary epithehal cells with the peanut lectin-horseradish peroxidase procedure. Histochemistry 73:607–624
Schlegel R, Banks-Schlegel S, Pinkus GS (1980) Immunohistochemical localization of keratin in normal human tissues. Lab Invest 42:91–96
Schmeller NT, Jorham D, Staehler G, Schmiedt E, Davis J, Drach GW (1986) Cytologic regression grading of hormone treated prostatic cancer. Prostate 9:1–7
Schmidt JD, Patterson MC (1966) Needle biopsy study of chronic prostatitis. J Urol 96:519–533
Schmidt JD, Welch MJ (1976) Sarcoma of the prostate. Cancer 37:1908–1912
Schroeder FH (1983) Current models and their relation to human disease. In: Hinman F (ed) Benign Prostatic Hypertrophy. Springer, Berlin Heidelberg New York
Schroeder FH, Blom JHM, Hop WCJ, Mostofi FK (1985 a) Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics. Prostate 6:81–100
Schroeder FH, Blom JHM, Hop WCJ, Mostofi FK (1985 b) Grading of prostate cancer (II): The prognostic significance of the presence of multiple architectural patterns. Prostate 6: 403–422
Schroeder FH, Hop WCJ, Blom JHM, Mostofi FK (1985 c) Grading of prostate cancer (III): Multivariate analysis of prognostic parameters. Prostate 7:13–20
Schron DS, Gipson T, Mendelsohn G (1984) The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study. Cancer 53:2478–2480
Schuhrke TD, Kaplan GW (1978) Prostatic utricle cysts. (Müllerian duct cysts). J Urol 119: 765–767
Schulze H, Barrack ER (1987 a) Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology 121:1773–1783
Schulze H, Barrack ER (1987 b) Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia. Prostate 11:145–162
Schuman LM, Mandel JS (1980) Epidemiology of cancer in blacks. Prev Med 9:630–639
Schuman LM, Mandel J, Blackard C (1977) Epidemiologic study of prostatic cancer: Preliminary report. Cancer Treat Rep 61:181–186
Schuman LM, Mandel JS, Radke A, Seal V, Halberg F (1982) Some selected features of the epidemiology of prostatic cancer. In: Magnus K (ed) Trends in Cancer Incidence. Cancers and Practical Imphcations. Hemisphere, New York, pp 345–354
Schuppler J (1971) Malignant neurolemmoma of prostate gland. J Urol 106:903–905
Schweikert HK, Funke PJ, Tunn UW (1984) Androgene und Prostatacarcinom: Testosteronmetabolismus im menschlichen Prostatacarcinom. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Prostatakarzinom, pmi, Frankfurt, S12–18
Schweikert HK, Neumann F, Tunn UW (1988) Endokrinologische Aspekte der benignen Prostatahyperplasie. In: Helpap B, Senge Th, Vahlensieck W (Hrsg) Prostataerkrankungen. pmi, Frankfurt, S 51–59
Seemayer TA, Knaack J, Thelmo WL, Wang NS, Ahmed M (1975) Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Cancer 36:514–520
Seitz J, Aumüller G (1985) Cytochemistry and biochemistry of acid phosphatases: V. Elec—trophoretic studies on the heterogeneity of acid phosphatases from human prostate seminal fluid and leukocytes. Prostate 7:73–90
Seitz G, Schüder G (1987) Neoplasm to neoplasm metastasis. Pheochromocytoma harboring a metastasis of breast cancer. Pathol Res Pract 182:228–232
Seitz G, Kolles H, Niemeyer AH, Wernert N, Dhom G (1988) Zur Epidemiologie des Prostatakarzinoms im Saarland. Verh Dtsch Ges Urol 39:199–200
Senge TH (1983) Hormonstoffwechsel und Rezeptoren in der Prostata. In: Helpap B (Hrsg) Prostatahyperplasie, pmi, Frankfurt, S 87–95
Seppelt V, Sprenger E (1984) Nuclear DNA-cytophotometry in prostata carcinoma. Cytometry 5:258–262
Servadio C, Mukamel E, Kahan E (1984) Carcinoma of the prostate in Israel: Some epidemiological and therapeutical considerations. Prostate 5:375–382
Sesterhenn J, Mostofi FK, Davis CJ (1987) Basal cell hyperplasia and basal cell carcinoma. Lab Invest 56:71A
Sharkey FE, Dusenbery DM, Moyer JE, Barry JD (1984) Correlation between stage and grade in prostatic adenocarcinoma: A morphometric study. J Urol 132:602–605
Shimada H, Misagi K, Sasaki Y, Jizuka A, Nishihira H (1980) Carcinoma of the prostate in childhood and adolescence: Report of a case and review of the hterature. Cancer 46: 2534–2542
Shong-San C, Walters MN (1984) Adenoid cystic carcinoma of prostate. Report of a case. Pathology 16:337–338
Sigel A (1973) Entleerungs-Störungen der unteren Harnwege. In: Alken CE, Stähler W (Hrsg) Klinische Urologie. Thieme, Stuttgart, S 251 ff.
Simard C, Rognon LM, Silorce G (1964) Le problème du naevus bleu prostatique. Ann An—at Pathol 9:469–474
Simmonds M (1914) Über hämatogene Tuberkulose der Prostata. Virchows Arch 216:45–56
Slater D (1985) Carcinoid tumor of the prostate associated with inappropriate ACTH-secretion. Br J Urol 57:598
Smart CJ, Jenkins JD (1973) The role of transurethral prostatectomy in chronic prostatitis. Br J Urol 45:654–662
Smith BH, Dehner LP (1972) Sarcoma of the prostate gland. Am J CHn Pathol 58:43–50
Smith JA, Middleton RG (1984) Pelvic lymph node metastasis from prostatic cancer: Significance of disease extent. Abstract 228. American Urological Association Meeting. New Orleans
Smith JA, Seaman JP, Gleidman JB, Middleton RG (1983) Pelvic lymph node metastasis from prostatic cancer: Influence of tumor grade and stage in 452 consecutive patients. J Urol 130:290–292
Snowdon DA, Phillips RL, Choi W (1984) Diet, obesity and risk of fatal prostate cancer. Am J Epidemiol 120:244–250
Sogani PC, Whitmore WF (1987) Update in staging systems. In: Bruce AW, Trachtenberg J (eds) Adenocarcinoma of the prostate. Springer, Berlin Heidelberg New York Tokyo
Song GX, Lin CT, Wu JY, Lam KW, Li CY, Yam LT (1985) Immunoelectron microscopic demonstration of prostatic acid phosphatase in human hyperplastic prostate. Prostate 7: 63–71
Spieler P, Gloor F, Egle N, Bandhauer K (1976) Cytologic findings in transrectal aspiration biopsy on hormone and radio-treated carcinoma of the prostate. Virchows Arch [A] 372: 149–159
Spiro LH, Levine B (1974) Ectopic subvesical prostatic tissue. J Urol 112:631–633
Sprenger E, Michaehs WE, Vogt-Schaden M, Otto C (1976) The significance of DNA-flow—through fluorescence cytophotometry for the diagnosis of prostate carcinoma. Beitr Pathol 159:292–298
Springer C (1898) Zur Kenntnis der Cystenbildung aus dem Utriculus prostaticus. Z Heilk 19:459–474
Stamey TA (1980) Pathogenesis and treatment of urinary tract infections. Wilhams & Wilkins, Baltimore
Staszewski J, Haenszel W (1965) Cancer mortality among the Polish born in the United States. J Natl Cancer Inst 35:291–297
Steele R, Lees REM, Kraus AS, Rao C (1971) Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis 24:29–37
Sterrett GF, Heenan PJ, Wyche P, Papadimitriou JM (1975) Malakoplakia of the prostate: A morphological and biochemical study. Pathology 7:139–147
Stieve H (1930) Männliche Genitalorgane. In: Möllendorf von W (Hrsg) Handbuch der Mikroskopischen Anatomie des Menschen, 7. Bd, 2. Teil. Springer, Berhn
Stratton M, Evans DJ, Lampert JA (1986) Prostatic adenocarcinoma evolving into carcinoid: Selective effect of hormonal treatment. J Clin Pathol 39:750–756
Sutor DJ, Wooley SE (1974) The crystalline composition of prostatic calcuH. Br J Urol 46: 533–535
Swanson GM, Belle SH, Satariano WA (1985) Marital status and cancer incidence: Differences in the black and white population. Cancer Res 45:5883–5889
Szenes GC, Rubin DJ (1968) Squamous cell carcinoma in a Mullerian duct cyst. J Urol 100: 40
Talamini R, Vecchia CL, Decarli A, Negri E, Franceschi S (1986) Nutrition, social factors and prostatic cancer in a northern Itahan population. Br J Cancer 53:817–821
Tandler J, Zuckerkandl O (1922) Studien zur Anatomie und Klinik der Prostatahypertrophie. Springer, Berlin
Tannenbaum M (1975) Adenoid cystic or „salivary gland” carcinomas of prostate. Urology 6:238–239
Tanner FH, McDonald JR (1943) Granulomatous prostatitis. Arch Pathol 36:358–370
Taylor EW, Wheehs RG, Correa Jr RJ, Gibbons RP, Tate Mason J, Cummings KB (1977) Granulomatous prostatitis: Confusion clinically with carcinoma of the prostate. J Urol 117:316–318
Taylor HG, Lefkowitz M, Skoog SJ, Miles BJ, McLeod DG, Coggin JT (1984) Intracranial metastases in prostate cancer. Cancer 53:2728–2730
Tenniswood M (1986) Role of epithelial-stromal interactions in the control of gene expression in the prostate: An hypothesis. Prostate 9:375–385
Tepper SL, Jagirdar J, Heath D, Geller SA (1984) Homology between the female paraurethral (skene’s) glands and the prostate. Arch Pathol Lab Med 108:423–425
Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis C, Ordonez NG (1987) Small cell carcinoma of the prostate. Part 1. A clinico-pathologic study of 20 cases. Cancer 59:1803–1809
Towfighi J, Sadeghee S, Wheeler JE, Enterline HT (1972) Granulomatous prostatitis with emphasis on the eosinophilic variety. Am J Clin Pathol 58:630–641
Tribukait B, Rönström L, Esposti PL (1983) Quantitative and qualitative aspects of flow DNA-measurements related to the cytologic grade in prostatic carcinoma. Analyt Quantität Cytol 5: 107–111
Tulinius H (1977) Epidemiology of prostatic carcinoma. Ree Results Cancer Res 60:3–13
Tunn UW, Schüring B, Senge TH, Neumann F, Schweikert HK, Rohr HP (1980) Morpho—metric analysis of prostates in castrated dogs after treatment with androstenediol, estradiol and cyproterone acetate. Invest Urol 18:289–292
Tunn UW, Schweikert HU (1983) Endokrinologische Aspekte der Pathogenese der benignen Prostatahyperplasie. In: Helpap B (ed) Prostatahyperplasie, pmi, Frankfurt, pp 67–86
Ullmann AS, Ross OA (1967) Hyperplasia atypism and carcinoma in situ in prostatic periurethral glands. Am J Clin Pathol 37:497–504
Utz DC, Farrow GM (1969) Pathologic differentiation and prognosis of prostatic carcinoma. JAMA 209:1701–1703
Vilas E (1932) Über die Entwicklung des Utriculus prostaticus beim Menschen. Z Anat Entwickl Gesch 99:599–621
Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J, Hand P, Thor A, Schlorn J (1986) Expression of ras-oncogene p 21 in human prostate cancer. N Engl J Med 314:133–137
Virchow R (1853) Prostata-Concretionen beim Weib. Arch Pathol Anat Physiol 5:403–404
Voigt KD, Krieg M (1984) Biochemische Endokrinologie beim Prostatakarzinom. In: Helpap B, Senge TH, Vahlensieck W (Hrsg) Prostatakarzinom, pmi, Frankfurt, S 2–11
Voigt KD, Bartsch W (1987) Zur Rolle der Gewebssteroide bei benigner Hyperplasie und Prostatakarzinom. Urologe [A] 26:349–357
Vuitch MF, Mendelsohn G (1981) Relationship of ectopic ACTH production to tumor differentiation: A morphologic and immunohistochemical study of prostatic carcinoma with Cushing’s syndrome. Cancer 47:296–299
Wagner RK, Schulze KH, Jungblut PW (1975) Estrogen and androgen receptor in human prostate and prostatic tumor tissue. Acta Endocrinol (Copenh) [Suppl] 193:52
Walker PD, Karnik S, De Kernion JB, Pramberg JC (1984) Cell surface blood group antigens in prostatic carcinoma. Am J Clin Pathol 81:503–506
Walsh PC, Jewett HJ (1980) Radical surgery for prostatic cancer. Cancer 45:1906–1911
Walsh PC, Wilson JD (1976) The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57:1093–1097
Wang MC, Valenzuela CA, Murphy GP, Chu TM (1980) Purification of a human prostate specific antigen. Invest Urol 17:159–163
Wang WC, Papsidero LD, Kuriyama M, Valenzuela GP, Murphy GP, Chu TM (1981) Prostate antigen: A new potential marker for prostatic cancer. Prostate 2:89–96
Wasserstein PW, Goldman PL (1979) Primary carcinoid of prostate. Urology 13:318–320
Wasserstein PW, Goldman PL (1981) Diffuse carcinoid of prostate. Urology 28:407–409
Wegener F (1969) Die pneumogene allgemeine Granulomatose (P.G.)—sog. Wegener’sche Granulomatose. In: Kaufmann E, Stämmler M (Hrsg) Lehrbuch der speziellen Pathologischen Anatomie Erg. Bd 1,1. Hälfte, de Gruyter, Berlin, S 225–299
Weidner W, Weißbach L (1981) Praxisgerechte Diagnostik der unspezifischen Prostatitis. Urologe [B] 21:6–10
Weitzner ST (1973) Survival of patients with secondary carcinoma of prostate in the testis. Cancer 32:447–449
Wenk RE, Bhagavan BS, Levy R, Miller D, Weisburger W (1977) Ectopic ACTH, prostatic oat cell carcinoma and marked hypernatriemia. Cancer 40:773–778
Wernert N (1987) Morphologische und immunhistochemische Untersuchungen zur Orthologie und Pathologie der menschhchen Prostata. Habihtationsschrift Homburg/Saar
Wernert N, Dhom G (1984) Morphologie und Differentialdiagnose der cribriformen Prostatahyperplasie. Pathologe 5:27–32
Wernert N, Seitz G, Goebbels R, Dhom G (1986 a) Immunohistochemical demonstration of cytokeratins in the human prostate. Pathol Res Pract 181:668–674
Wernert N, Kern L, Seitz G, Goebbels R, Dhom G (1986 b) Morphology and immunohisto—chemistry of the utriculus prostaticus. Abstracts: Symposium cum participatione internationali. Progressus in Histochemia Generali, Apphcata Atque Diagnostica. Histochemia Myocardii, Smolenice, CSSR
Wernert N, Seitz G, Achtstätter TH (1987 a) Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 182:617–626
Wernert N, Seitz G, Dhom G (1987 b) Different markers in conservatively treated prostatic carcinoma and the estrogen receptor in the normal prostate. J Endocrinol Invest 10 [Suppl 2]: 43
Wernert N, Lüchtrath H, Seeliger H, Schäfer M, Goebbels R, Dhom G (1987 c) Papillary carcinoma of the prostate, location and immunohistochemistry. The histogenesis and entity of so-called endometrioid carcinoma. Prostate 10:123–131
Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G (1988 a) Investigations of the estrogen (ER-ICA test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch [A] 412:387–391
Wernert N, Goebbels R, Seitz G, Hinkeldey K, Dhom G (1988 b) Histogenese von Plattenepithelcarcinomen in der Prostata. Verh Dtsch Ges Pathol 72:451
Wojciechowski G (1974) Granulomatose Prostatitis. Inauguraldissertation Homburg/Saar
Wolf RM, Schneider L, Pontes JE, Englander L, Karr JP, Murphy GP, Sandberg AA (1985) Estrogen and progestin receptors in human prostatic carcinoma. Cancer 55: 2477–2481
Woolf CM (1960) An investigation of the famihal aspect of carcinoma of the prostate. Cancer 13:739–744
Wullstein HK, Müller HA (1975) Zur zytologischen Diagnose der granulomatösen Prostatitis im Prostata-Aspirat. Verh Dtsch Ges Pathol 27:333
Wynder EL, Mabuchi K, Whitmore WF (1971) Epidemiology of the prostate. Cancer 28: 344–360
Yamada Y (1986) Focal palisading granuloma in the prostate and bladder. Acta Pathol Jpn 36:1813–1822
Yatani R, Shiraioshi T, Nakakuki K, Kusano J, Takanari H, Hayashi T, Stemmermann GN (1988) Trends in frequency of latent prostate carcinoma in Japan from 1965–79 to 1982—86. J N C J 80:683–687
Yokota T, Yamashita Y, Okuzono Y, Takahashi M, Fujihara SH, Akizuki SH, Ishihara T, Uchino F, Iwata T (1984) Malignant cystosarcoma phyllodes of the prostate. Acta Pathol Jpn 34:663–668
Young BW, Lagios MD (1973) Endometrial (papillary) carcinoma of the prostatic utricle-response to orchiectomy. Cancer 32:1293–1300
Young RH, Scully RE (1987) Pseudosarcomatous lesions of the urinary bladder, prostate gland, and urethra. Arch Pathol Lab Med 111: 354–358
Young RH, Frierson Jr HF, Mills SE, Kaiser JS, Talboth WH, Bhan AK (1988) Adenoid cystic-like tumor of the prostate gland. A report of two cases and review of the literature on „adenoid cystic carcinoma” of the prostate. Am J Clin Pathol 89:49–56
Yu H, Harris E, Wynder EL (1988) Case control-study of prostate cancer and socioeconomic factors. Prostate 13:317–325
Zaloudek C, Williams JW, Kempson RL (1976) „Endometrial” andenocarcinoma of the prostate. Cancer 37:2255–2262
Zaridze DG, Boyle P, Smans M (1984) International trends in prostatic cancer. Int J Cancer 33:223–230
Zaviacic M (1984 a) Enzyme histochemistry of the adult human female prostate: Acid phosphatase distribution. Cell Mol Biol 30:545–551
Zaviacic M (1984 b) Enzyme histochemistry of the adult human female prostate: Hydrolase and dehydrogenase distribution. Cell Mol Biol 30:537–543
Zaviacic M, Zaviacikova A, Obesukova J, Zajikova M, Blazekova J (1985) Enzyme histo—chemical profile of the adult human female prostate (paraurethral glands). Histochem 17: 564–566
Zeigel RF, Arya SK, Horszewicz JJ, Carter WA (1977) A status report. Human prostatic carcinoma, with emphasis on potential for viral etiology. Oncology 34:29–44
Zetterberg A, Esposti PL (1976) Cytophotometric DNA-analysis of aspirated cells from prostatic carcinoma. Acta Cytol 20:46–57
Zincke H, Farrow GM, Myers RP, Benson RC, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498–501
Zondek LH, Zondek TH (1971) The foetal and neonatal prostate in congenital malformation of the urinary tract. Virchows Arch [A] 354:197–208
Zondek LH, Zondek TH (1972) The prostate in the neonate and infant in cryptorchism and hypospadias. Z Kinderheilkd 111: 293–306
Zondek LH, Zondek TH (1974 a) The prostatic utricle in the fetus and infant. Urol Int 29: 458–465
Zondek LH, Zondek TH (1980) Observations on the prostatic utricle in the fetus and infant. Acta Paed Scand 69:257–258
Zondek TH, Zondek LH (1974 b) The fetal and neonatal prostate. In: Symposium on Normal and Abnormal Growth of the Prostate. Thomas, Springfield, pp 5–28
Zumoff B, Levin J, Strain GW, Rosenfeld RS, O’Conner J, Freed SZ, Kream J, Whitmore WS, Fukushima DK, Hellman L (1982) Abnormal levels of plasma hormones in men with prostate cancer. Evidence toward a „two-disease” theory. Prostate 3:579–588
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dhom, G., Wernert, N. (1991). Prostata. In: Pathologie des männlichen Genitale. Spezielle pathologische Anatomie, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-51158-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-51158-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-51159-2
Online ISBN: 978-3-642-51158-5
eBook Packages: Springer Book Archive